BlackRock’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

BlackRock’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.4K	Hold	663	–	–	﹤0.01%	5139
2026 Q1	$52.5K	Hold	663	–	–	﹤0.01%	5119
2025 Q4	$54.5K	Hold	663	–	–	﹤0.01%	5033
2025 Q3	$46.3K	Hold	663	–	–	﹤0.01%	4990
2025 Q2	$42.5K	Hold	663	–	–	﹤0.01%	5019
2025 Q1	$42.1K	Hold	663	–	–	﹤0.01%	4949
2024 Q4	$44.1K	Buy	663 +450	+211%	+$31K	﹤0.01%	4976
2024 Q3	$14.9K	Hold	213	–	–	﹤0.01%	4965
2024 Q2	$13.8K	Hold	213	–	–	﹤0.01%	5041
2024 Q1	$13.8K	Hold	213	–	–	﹤0.01%	5058
2023 Q4	$14K	Hold	213	–	–	﹤0.01%	5121
2023 Q3	$12.1K	Hold	213	–	–	﹤0.01%	5187
2023 Q2	$13.1K	Hold	213	–	–	﹤0.01%	5237
2023 Q1	$13.4K	Hold	213	–	–	﹤0.01%	5300
2022 Q4	$13.5K	Hold	213	–	–	﹤0.01%	5424
2022 Q3	$13K	Hold	213	–	–	﹤0.01%	5568
2022 Q2	$12K	Hold	213	–	–	﹤0.01%	5609
2022 Q1	$13K	Hold	213	–	–	﹤0.01%	5619
2021 Q4	$15K	Hold	213	–	–	﹤0.01%	5574
2021 Q3	$16K	Hold	213	–	–	﹤0.01%	5422
2021 Q2	$16K	Hold	213	–	–	﹤0.01%	5309
2021 Q1	$16K	Buy	+213	New	+$16.1K	﹤0.01%	5051

Other funds holding PBE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.75B AUM 28.61% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

BlackRock's PBE Position: Q2 2026 in Review

BlackRock held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q2 2026 at 663 shares worth $59.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5139.

BlackRock first reported a position in PBE in Q1 2021 and has held it in 22 quarters since. 105 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

BlackRock held 663 shares of Invesco Biotechnology & Genome ETF worth $59.4K as of Q2 2026.
BlackRock left its Invesco Biotechnology & Genome ETF share count unchanged in Q2 2026.
Invesco Biotechnology & Genome ETF made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5139 holding.
BlackRock first reported a position in Invesco Biotechnology & Genome ETF in Q1 2021 and has held it in 22 quarters since.
105 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.